Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by lscfaon Mar 26, 2021 3:39pm
130 Views
Post# 32888049

RE:33m subscription

RE:33m subscription

Get rid of the bloody toxic convertible note holder.....

User image        




Redwine12345 wrote: Was checking again how the subscription went. The buyer Cantor Fitzgerald Canada Corporation agreed to buy 34.5m units at 0.58. Total proceeds 20m. Next day they increased to 50m units or $29m, and few days later they bought additional 7.5m units. My bank showing that there is 184.6m outstanding shares. 
From tyechnical perspective, it is out of oversold territory and now hanging in there. Possible double bottom at .45. I hope this is the case. There is a slight divergence on bunch of indicators suggesting potential upside. I like what I see.
But I don;t like that there is 5m in short posittion. If it is a dumb investor is shorting, I am ok with this, but if it is a market maker (or Wall Street player), then there is potential for downside.
Crossroads would be a nice term to discribe the current share price. 
Bollinger Bands support this view (right in the middle). Time will show. My bet is on the smart money.

 

<< Previous
Bullboard Posts
Next >>